Floatz logo

FLORTAUCIPIR

Traumatic Brain Injury

University of North Carolina, Chapel HillSmall moleculePhase 2Active
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
73/ 100

Competitive context

92 Active assets in the Traumatic Brain Injury cohort.

Asset / SponsorPhaseRating
MELATONIN
Children's National Research Institute
Phase 4BBB
Valproic Acid
Northwestern University
Phase 4BBB
PROPRANOLOL
Tanta University
Phase 4BBB
NEPENTHE
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB
Amantadine
SHINKEI Therapeutics, Inc
Phase 4BB

View all 50 →

Same molecule, other indications

FLORTAUCIPIR is also rated in:

Alzheimer diseaseDormant
BBB
Indicative ·
73 / 100
View asset →
frontotemporal dementiaDormant
BBB
Indicative ·
73 / 100
View asset →
primary progressive aphasiaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →